Novel p53 target genes involved in cross talk between oncogenic signals and p53 pathways.
| Project/Area Number |
21790299
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
General medical chemistry
|
|---|
| Research Institution | National Cancer Center Research Institute and Research Center for Innovative Oncology, National Cancer Center Hospital East |
|---|
Principal Investigator |
OHKI Rieko 独立行政法人国立がん研究センター, 研究所, 研究員 (70356252)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 細胞内シグナル伝達 / P53 / Akt / がん抑制遺伝子 / がん遺伝子 / 癌 / p53 |
|---|
| Research Abstract |
p53 and Akt are critical players regulating tumorigenesis with opposite effects : While p53 transactivates target genes to exert its function as a tumor suppressor, Akt phosphorylates its substrates and transduces downstream survival signals. In addition, p53 and Akt negatively regulate each other to balance survival and death signals within a cell. We now identify PHLDA3 as a p53 target gene, which encodes a PH domain only protein. We find that PHLDA3 competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation. Loss of the PHLDA3 genomic locus was frequently observed in primary lung and pancreatic cancers, suggesting a role of PHLDA3 in tumor suppression.
In addition, we have found that cancer susceptibility polymorphism of p53 at codon 72 affects oncogenic signaling pathways regulated by Mdm2 and Ras.
Collectively, our results reveal a new mode of coordination between p53 and oncogenic signalling pathways.
|
Report
(3 results)
Research Products
(28 results)
-
-
-
-
-
-
[Journal Article] Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein^#.(^#corresponding author)
Author(s)
Chikako Ozeki, Tatsuhiro Shibata, Takashi Kohno, Yuichiro Sawai, Koji Okamoto, Jun Yokota, Fumio Tashiro, Seiichi Tanuma, Ryuichi Sakai, Tatsuya Kawase, Issay Kitabayashi, Yoichi Taya, Rieko Ohki.
-
Journal Title
Journal of Biological Chemistry (in press.)
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
